<DOC>
	<DOCNO>NCT01996124</DOCNO>
	<brief_summary>Chronic Obstructive Pulmonary disease ( COPD ) one major clinical entity cause thousand death every year world weight lot health care system every country term direct indirect cost . The physiopathological modification characterise COPD represent irreversible ( sometimes partially reversible ) airflow obstruction , bronchiolar inflammation . Lungs develop emphysema lack elastic recoil imply increase resistance airflow obstruction due loss lung parenchyma support elastic structure . All modification produce air trap lung hyperinflation . The latter precisely cause symptom particularly dyspnoea often heavily perceive COPD patient drive limitation daily activity . Lung hyperinflation alteration occur COPD imply gas retention increase pulmonary vascular resistance . Considering rib cage limit elastic property , effect gas trap lung parenchymal damage mediastinum particularly heart mechanic indisputable . Together alveolar hypoxia , lung hyperinflation responsible development , disease progress , cor pulmonale . Tha latter cause pulmonary hypertension increase mechanic load right heart chamber contraction relaxation . Those alteration may effect leave heart chamber . Airflow obstruction COPD usually treat inhaled bronchodilator corticosteroid . The main used bronchodilator represent beta 2 agonist ( short , long ultra-long acting ) anticholinergic inhalatory drug , also short , long ultra long act . Among ultra long act beta 2 agonist , indacaterol characterise quick onset action ( 5 minute ) , guarantee effective bronchodilation duration 24 hour . It also know important effect reduce lung hyperinflation decrease residual volume consequently allow increase inspiratory capacity . The purpose study evaluate effect indacaterol lung hyperinflation COPD subject stage lung air trapping , consequent potential effect heart performance evaluate cardiac trans thoracic echo color doppler .</brief_summary>
	<brief_title>Acute Effect Pulmonary Desufflation Cardiac Performance COPD Patients</brief_title>
	<detailed_description>In paper recently publish , Barr et al , suppose pulmonary emphysema bronchial obstruction inversely related ventricular telediastolic volume , ejection volume ejection fraction patient severe pulmonary disease . The mechanism involve development cor pulmonale increase pulmonary vascular resistance , lung hyperinflation hypoxic vascular constriction . All mention contribute generation right cardiac failure consequently , leave cardiac failure . The author assess lung hyperinflation CT scan , pulmonary function spirometry , cardiac kinetic mechanic magnetic resonance . They conclude amount emphysema bronchial obstruction relate bad telediastolic leave ventricular volume stroke volume , relation find ejection fraction . It evident patient severe pulmonary disease present cardiac disease , sub-clinic modification one day may lead development cor pulmonale . The effect bronchodilation , effect lung hyperinflation , may role produce modification context . That 's aim study center evaluation effect bronchodilation firstly diastolic right ventricular function also interventricular septum motility , ejection fraction kinetics right cardiac chamber assess cardiac echocardiography</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Signature inform consent COPD patient age rag 50 85 year old Patients least history COPD one year COPD patient clinically stable last three month COPD subject FEV1 ( Forced Expiratory Volume one second ) &lt; 70 % predict value FEV1/FVC ( Forced Vital Capacity ) &lt; 88 % ( male ) &lt; 89 % ( female ) LLN ( Lower Levels Normality ) COPD former active smoker least smoke history 20 pack year Residual Volume ( RV ) &gt; = 125 % predict value No Cardiac ultrasound sign Cor Pulmonale Acute Bronchial Exacerbation recruitment Fertile woman age 18 50 year old active period Pregnancy Subjects enrol clinical trial take part one month precede enrollment . FEV1/FVC 70 % predict value basal condition FEV1 70 % predict value basal condition Residual Volume &lt; 125 % predict value Known deficit alpha 1 antitrypsin Subjects underwent Lung Volume Reduction Surgery ( LVRS ) Subjects know positivity Human Immunodeficiency Virus ( HIV ) Misuse alcool drug Lack compliance perform respiratory test Subjects capable follow study prescription psychic disorder language problem . Long Term Oxygen Therapy flow &gt; 6 litre per minute ( l/min ) rest Cor Pulmonale Patients take Indacaterol cardiologic reason</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>Pulmonary Hyperinflation</keyword>
	<keyword>Ultra Long Acting Beta 2 Agonists</keyword>
	<keyword>Cor Pulmonale</keyword>
	<keyword>Cardiac performance</keyword>
</DOC>